The Age-stratified Cost of Biliary Atresia: A MarketScan®-Based Cost Analysis
Topic overview
This cost-analysis study examines healthcare expenditures for biliary atresia patients in the U.S., comparing outcomes based on timing of Kasai portoenterostomy. The research investigates whether early surgical intervention (before 60 days) reduces overall costs by potentially preventing liver failure and transplantation.
Key takeaways
- Biliary atresia is the leading cause of pediatric liver failure requiring transplantation in the US.
- Kasai portoenterostomy before 60 days of age may reduce overall healthcare costs compared to later intervention.
- Early diagnosis of BA is critical to optimize surgical timing and potentially avoid liver transplantation.
- Healthcare cost analysis supports the clinical imperative for rapid diagnostic workup in neonatal cholestasis.
- Age at Kasai procedure is a key economic and clinical outcome determinant in biliary atresia management.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. The Age-stratified Cost of Biliary Atresia: A MarketScan®-Based Cost Analysis. GlobalCastMD Medical Library. 2025-02-17. https://dev.library.globalcastmd.com/article/9884?via_space=staycurrentmd
Comments